Total Funding
43
47
Total FundingPost-IPO Equity raised
Growth Score
-12 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
185636
Nephros develops water purification products and pathogen detection systems for the medical and commercial markets.
- Andrew Astor: Chief Executive OfficerPast Role: Nephros, Chief Financial Officer
- Judy Krandel: Chief Financial OfficerPast Role: Recruiter.com, Chief Financial Officer
About the Company
Nephros is a commercial-stage company that develops and sells high-performance water purification products to the medical device and commercial markets. The company ultrafilters used in hospitals and medical clinics for added protection in retaining bacteria (e.g., Legionella, Pseudomonas) and viruses from water, providing barriers that assist in
improving infection control in showers, sinks, and ice machines. Additionally, Nephros ultrafilters also used by dialysis centers for assisting in the added removal of endotoxins and other biological contaminants from the water and bicarbonate concentrate supplied to hemodialysis machines and patients.
The company was founded in 1997 and is based in South Orange, New Jersey, United States.
